Last reviewed · How we verify
NCT05245422
Acceptance of a Partially Hydrolyzed Formula
NA trial testing Infant Formula - Partially hydrolyzed protein in Fussy Infant (Baby) in 148 participants. Completed in 14 July 2023.
14 July 2023
Quick facts
| Lead sponsor | Mead Johnson Nutrition |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | supportive care |
| Enrollment | 148 |
| Start date | 28 February 2022 |
| Primary completion | 14 July 2023 |
| Estimated completion | 14 July 2023 |
| Sites | 11 locations across United States |
Drugs / interventions tested
- Infant Formula - Partially hydrolyzed protein
- Infant Formula - Intact protein
Conditions studied
- Fussy Infant (Baby) — all drugs for Fussy Infant (Baby) →
Sponsor
Mead Johnson Nutrition — full company profile →
Who can join
Adults 15 Days to 75 Days, any sex, with Fussy Infant (Baby). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A multi-center, double-blind, controlled, parallel-designed, prospective trial intended to evaluate the nutritive effects of a partially hydrolyzed cow's milk protein infant formula on infant fussiness.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A Randomized Controlled Trial of a Partially Hydrolyzed Formula on Comfort Measures in Fussy Infants.
Fabrizio V, Bohan Brown MM, Boucher P, Boyd S, et al · · 2025 · PMID 41323693 · DOI 10.1016/j.cdnut.2025.107574
Verify or expand the search:
- PubMed search for NCT05245422
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Mead Johnson Nutrition trials
Trials by the same sponsor.
- NCT07513506 — Extensively Hydrolyzed Formula Growth Monitioring Study (GMS) · NA · not yet recruiting
- NCT07498192 — Thai Baby Study Phase 1 · not yet recruiting
- NCT06318117 — Reason for Prescribing Rice Infant Formula · completed
- NCT05744193 — Feeding Study in VLBW Premature Infants · NA · terminated
- NCT05247879 — Clinical Effectiveness and Safety of a Novel Oral Rehydration Solution · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05245422 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mead Johnson Nutrition
- Last refreshed: 18 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05245422.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing